Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events.
Miao LinLiubing HuSi ShenJiyue LiuYanyan LiuYixian XuHonglin ChenKazuo SugimotoJianshuang LiIkuo KamitsukasaTakaki HiwasaHao WangLiangxue LaiPublished in: Stroke and vascular neurology (2023)
Through the findings of SEREX and bioinformatics pan-cancer analysis, we concluded that PABPC1 might serve as a potential biomarker for the prediction and diagnosis of AS and pan-cancer.